Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CNO Financial Group, Inc. (CNO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
24.41-0.49 (-1.97%)
At close: 04:00PM EST
24.41 0.00 (0.00%)
After hours: 04:58PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close24.90
Open24.86
Bid24.47 x 800
Ask27.60 x 800
Day's Range24.35 - 25.01
52 Week Range21.06 - 27.89
Volume791,508
Avg. Volume856,154
Market Cap3.01B
Beta (5Y Monthly)1.35
PE Ratio (TTM)7.54
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.52 (2.06%)
Ex-Dividend DateDec 09, 2021
1y Target EstN/A
  • Business Wire

    NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors

    ELMSFORD, N.Y., January 13, 2022--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced its board of directors has appointed Ms. Aurora (Rori) Cassirer and Ms. Maria (Lulu) Schroeder to serve as independent directors effective today.

  • GlobeNewswire

    NanoVibronix Adjourns Special Meeting of Stockholders

    Elmsford, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, December 21, 2021, has been adjourned to allow for more time for stockholders to vote due to a lack of quorum. The meeting has been scheduled to reconvene on December 29, 2021 at 10:00 a.m. Eastern time and will be held virtually online at www.virtualshareholdermeeting.com/NAOV2021SM2. Du

  • Business Wire

    NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion

    ELMSFORD, N.Y., December 21, 2021--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has commenced sales in Europe with the signing of a distribution agreement with Medina Healthcare Ltd ("Medina") in Malta.

Advertisement
Advertisement